Nutrient Control of Insulin Secretion in Isolated Normal Human Islets

Pancreatic islets were isolated from 16 nondiabetic organ donors and, after culture for ∼2 days in 5 mmol/l glucose, were perifused to characterize nutrient-induced insulin secretion in human islets. Stepwise increases from 0 to 30 mmol/l glucose (eight 30-min steps) evoked concentration-dependent insulin secretion with a threshold at 3–4 mmol/l glucose, Km at 6.5 mmol/l glucose, and Vmax at 15 mmol/l glucose. An increase from 1 to 15 mmol/l glucose induced biphasic insulin secretion with a prominent first phase (peak increase of ∼18-fold) and a sustained, flat second phase (∼10-fold increase), which were both potentiated by forskolin. The central role of ATP-sensitive K+ channels in the response to glucose was established by abrogation of insulin secretion by diazoxide and reversible restoration by tolbutamide. Depolarization with tolbutamide or KCl (plus diazoxide) triggered rapid insulin secretion in 1 mmol/l glucose. Subsequent application of 15 mmol/l glucose further increased insulin secretion, showing that the amplifying pathway is operative. In control medium, glutamine alone was ineffective, but its combination with leucine or nonmetabolized 2-amino-bicyclo [2,2,1]-heptane-2-carboxylic acid (BCH) evoked rapid insulin secretion. The effect of BCH was larger in low glucose than in high glucose. In contrast, the insulin secretion response to arginine or a mixture of four amino acids was potentiated by glucose or tolbutamide. Palmitate slightly augmented insulin secretion only at the supraphysiological palmitate-to-albumin ratio of 5. Inosine and membrane-permeant analogs of pyruvate, glutamate, or succinate increased insulin secretion in 3 and 10 mmol/l glucose, whereas lactate and pyruvate had no effect. In conclusion, nutrient-induced insulin secretion in normal human islets is larger than often reported. Its characteristics are globally similar to those of insulin secretion by rodent islets, with both triggering and amplifying pathways. The pattern of the biphasic response to glucose is superimposable on that in mouse islets, but the concentration-response curve is shifted to the left, and various nutrients, in particular amino acids, influence insulin secretion within the physiological range of glucose concentrations.

[1]  D. Finegold,et al.  The Glucokinase Glucose Sensor in Human Pancreatic Islet Tissue , 1986, Diabetes.

[2]  S. Ashcroft,et al.  Insulin release from human pancreatic islets in vitro , 1980, Diabetologia.

[3]  I. Campbell,et al.  Effects of glucose and D-3-hydroxybutyrate on human pancreatic islet cell function. , 1985, Clinical science.

[4]  U. Boggi,et al.  Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients , 2005, Diabetologia.

[5]  J. Henquin,et al.  Unbound rather than total concentration and saturation rather than unsaturation determine the potency of fatty acids on insulin secretion , 1999, Molecular and Cellular Endocrinology.

[6]  M. Magnuson,et al.  The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. , 2006, Diabetes.

[7]  R. Turner,et al.  The beta cell glucose stimulus-response curve in normal humans assessed by insulin and C-peptide secretion rates. , 1988, Metabolism: clinical and experimental.

[8]  V. Poitout,et al.  Palmitate potentiation of glucose-induced insulin release: a study using 2-bromopalmitate. , 2003, Metabolism: clinical and experimental.

[9]  C. Stanley,et al.  A Signaling Role of Glutamine in Insulin Secretion* , 2004, Journal of Biological Chemistry.

[10]  M. Bozem,et al.  Inosine partially mimics the effects of glucose on ionic fluxes, electrical activity, and insulin release in mouse pancreatic B-cells , 1987, Pflügers Archiv - European Journal of Physiology.

[11]  J. Squifflet,et al.  A Simple Method Using a Polymethylpenten Chamber for Isolation of Human Pancreatic Islets , 2005, Pancreas.

[12]  D. Pipeleers,et al.  Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. , 1996, The Journal of clinical investigation.

[13]  W. Saris,et al.  Plasma insulin responses after ingestion of different amino acid or protein mixtures with carbohydrate. , 2000, The American journal of clinical nutrition.

[14]  G. Boden,et al.  Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes. , 1999, Diabetes.

[15]  P. Butler,et al.  Diazoxide attenuates glucose-induced defects in first-phase insulin release and pulsatile insulin secretion in human islets. , 2003, Endocrinology.

[16]  E. Cerasi,et al.  Quantitative Study on the Potentiating Effect of Arginine on Glucose-induced Insulin Response in Healthy, Prediabetic, and Diabetic Subjects , 1974, Diabetes.

[17]  B. Wolf,et al.  Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. , 2004, Diabetes.

[18]  M. Christie,et al.  Properties of isolated human islets of langerhans: insulin secretion, glucose oxidation and protein phosphorylation , 1985, Diabetologia.

[19]  Camillo Ricordi,et al.  Automated Method for Isolation of Human Pancreatic Islets , 1988, Diabetes.

[20]  F. Bertuzzi,et al.  Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. , 1999, Diabetes.

[21]  G. Grodsky,et al.  Dynamics of insulin secretion by the perfused rat pancreas. , 1968, Endocrinology.

[22]  W. Zawalich,et al.  Insulin secretion, inositol phosphate levels, and phospholipase C isozymes in rodent pancreatic islets. , 2000, Metabolism: clinical and experimental.

[23]  L. Satin,et al.  Insulin secretion in the conscious mouse is biphasic and pulsatile. , 2006, American journal of physiology. Endocrinology and metabolism.

[24]  E. Cerasi Mechanisms of glucose stimulated insulin secretion in health and in diabetes: Some re-evaluations and proposals , 1975, Diabetologia.

[25]  J. Henquin,et al.  Triggering and amplifying pathways of regulation of insulin secretion by glucose. , 2000, Diabetes.

[26]  M. J. MacDonald,et al.  Perspective: emerging evidence for signaling roles of mitochondrial anaplerotic products in insulin secretion. , 2005, American journal of physiology. Endocrinology and metabolism.

[27]  D. Pipeleers,et al.  The Changes in Adenine Nucleotides Measured in Glucose-stimulated Rodent Islets Occur in β Cells but Not in α Cells and Are Also Observed in Human Islets* , 1998, The Journal of Biological Chemistry.

[28]  J. Squifflet,et al.  A Simple Method Using a Polymethylpenten Chamber for Isolation of Human Pancreatic Islets , 2004, Pancreas.

[29]  J. Halter,et al.  Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. , 1984, The Journal of clinical investigation.

[30]  B. Ahrén,et al.  In Vivo and In Vitro Glucose-Induced Biphasic Insulin Secretion in the Mouse Pattern and Role of Cytoplasmic Ca 2 and Amplification Signals in-Cells , 2006 .

[31]  K. Gillis,et al.  Metabolite-Regulated ATP-Sensitive K+ Channel in Human Pancreatic Islet Cells , 1989, Diabetes.

[32]  N. Welsh,et al.  Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  K. Polonsky The β-Cell in Diabetes: From Molecular Genetics to Clinical Research , 1995, Diabetes.

[34]  P. J. Randle,et al.  Isolation of human pancreatic islets capable of releasing insulin and metabolising glucose in vitro. , 1971, Lancet.

[35]  P. Lacy,et al.  Pulsatile Insulin Secretion from Isolated Human Pancreatic Islets , 1994, Diabetes.

[36]  M. MacDonald Differences between mouse and rat pancreatic islets: succinate responsiveness, malic enzyme, and anaplerosis. , 2002, American journal of physiology. Endocrinology and metabolism.

[37]  D Pipeleers,et al.  Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. , 1995, The Journal of clinical investigation.

[38]  F. Ashcroft,et al.  The ATP- and tolbutamide-sensitivity of the ATP-sensitive K-channel from human pancreatic B cells , 1989, Diabetologia.

[39]  M. Ravier,et al.  Hierarchy of the β‐cell signals controlling insulin secretion , 2003, European journal of clinical investigation.

[40]  C. Ricordi,et al.  Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: partial reversibility after an additional culture in a normal glucose medium. , 1991, The Journal of clinical endocrinology and metabolism.

[41]  M. Dunne,et al.  Glucose activates both K(ATP) channel-dependent and K(ATP) channel-independent signaling pathways in human islets. , 1998, Diabetes.

[42]  P. Squires,et al.  The Extracellular Calcium-Sensing Receptor on Human-Cells Negatively Modulates Insulin Secretion , 2000 .

[43]  A. Lansner,et al.  Glucose-induced [Ca2+]i abnormalities in human pancreatic islets: important role of overstimulation. , 2000, Diabetes.

[44]  F. Bertuzzi,et al.  Human islets chronically exposed in vitro to different stimuli become unresponsive to the same stimuli given acutely: evidence supporting specific desensitization rather than beta-cell exhaustion. , 1992, The Journal of clinical endocrinology and metabolism.

[45]  Myriam Nenquin,et al.  In vivo and in vitro glucose-induced biphasic insulin secretion in the mouse: pattern and role of cytoplasmic Ca2+ and amplification signals in beta-cells. , 2006, Diabetes.

[46]  M. Düfer,et al.  Methyl pyruvate stimulates pancreatic beta-cells by a direct effect on KATP channels, and not as a mitochondrial substrate. , 2002, The Biochemical journal.

[47]  O. Berglund Different dynamics of insulin secretion in the perfused pancreas of mouse and rat. , 1980, Acta endocrinologica.

[48]  S. Lenzen Insulin secretion by isolated perfused rat and mouse pancreas. , 1979, The American journal of physiology.

[49]  S. Jasko,et al.  Therapy , 1881, The American journal of dental science.

[50]  W. Malaisse,et al.  Insulinotropic action of methyl pyruvate: enzymatic and metabolic aspects. , 1996, Archives of biochemistry and biophysics.

[51]  M. Ravier,et al.  Dual mechanism of the potentiation by glucose of insulin secretion induced by arginine and tolbutamide in mouse islets. , 2006, American journal of physiology. Endocrinology and metabolism.

[52]  U. Boggi,et al.  Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion. , 2004, American journal of physiology. Endocrinology and metabolism.

[53]  S. Ashcroft,et al.  Acute effects of fatty acids on insulin secretion from rat and human islets of Langerhans. , 2002, The Journal of endocrinology.

[54]  M. Trucco,et al.  Protection of Human Islets from the Effects of Interleukin-1β by Adenoviral Gene Transfer of an IκB Repressor* , 2000, The Journal of Biological Chemistry.

[55]  J. Halter,et al.  Potentiation of Insulin Secretion to Nonglucose Stimuli in Normal Man by Tolbutamide , 1980, Diabetes.

[56]  K. Gillis,et al.  Electrophysiology of Stimulus-Secretion Coupling in Human β-Cells , 1992, Diabetes.

[57]  M. Ravier,et al.  The Elevation of Glutamate Content and the Amplification of Insulin Secretion in Glucose-stimulated Pancreatic Islets Are Not Causally Related* , 2002, The Journal of Biological Chemistry.

[58]  M. Mcdaniel,et al.  Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets. , 1996, The American journal of physiology.

[59]  M. Byrne,et al.  Insulin secretion and clearance during low-dose graded glucose infusion. , 1995, The American journal of physiology.

[60]  J. Gerich,et al.  Dose-response characteristics for glucose-stimulated insulin release in man and assessment of influence of glucose on arginine-stimulated insulin release. , 1990, Metabolism: clinical and experimental.

[61]  J. Westman,et al.  Survival of isolated human islets of Langerhans maintained in tissue culture. , 1976, The Journal of clinical investigation.

[62]  M. Köhler,et al.  Oscillations in cytoplasmic free calcium concentration in human pancreatic islets from subjects with normal and impaired glucose tolerance , 1994, Diabetologia.